The Latest Breaking News from MedWatch

About Half of GLP-1 Users Start New Supplements, Yet None Need FDA Approval Before Reaching Store Shelves

About half of GLP-1 users start new supplements, but none need FDA approval before sale. Here are the ones that have expert support for managing side effects.

Medical Daily · 4h ago

Four Lots of Edwards Mitral Valve Delivery Systems Pulled After Balloon Bursts Linked to One Patient Death

FDA flags four lots of Edwards' Commander M mitral valve delivery system after balloon bursts tied to one death. What patients should know.

Medical Daily · Oct 17

Hospitals Must Destroy Whole Medline Kits, Not Just Recalled BD ChloraPrep Applicators, in New Class I Recall

The FDA classified Medline's removal of kits with recalled BD ChloraPrep applicators as a Class I recall. Customers must destroy the entire kit.

Medical Daily · Oct 15

Forever Chemicals Are Inside Catheters and Heart Implants, and Federal Regulators See No Reason to Remove Them

The FDA added a PFAS FAQ for medical devices on Sept. 1, explaining why fluoropolymers in catheters and stents differ from PFAS in drinking water.

Medical Daily · Sep 2

Baxter Recalls Three Intravenous Solutions on the Same Day Over Fiberglass and Stainless Steel Particle Concerns

Baxter recalled three IV solutions due to possible fiberglass and stainless steel particles. Here are the lots, the states, and who is affected.

Medical Daily · Aug 28

Pain Relief Product Sold Online Hides a Prescription Steroid, and Quitting It Suddenly Carries Its Own Danger

FDA lab testing found undeclared dexamethasone in Qu Feng Huo Lou Dan, a pain product sold online. Do not stop it abruptly on your own.

Medical Daily · Aug 26